Skip to main content
AMGN
NASDAQ Life Sciences

FDA Proposes Withdrawing Amgen's Tavneos From U.S. Market

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$373.15
Mkt Cap
$200.502B
52W Low
$269.77
52W High
$391.29
52W Position info
38% above low
Off High info
4.6% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

AMGN sits 38% above its 52-week low of $269.77.

Summary

The FDA has formally proposed withdrawing Amgen's rare-disease drug Tavneos from the U.S. market, escalating a safety saga that began with Japanese warnings in May and a NEJM trial retraction in early July. Amgen strongly disagrees and has submitted data seeking a hearing — a direct challenge that sets up a high-stakes regulatory fight. Tavneos generated $200M+ in annual sales; losing U.S. approval would erase a meaningful revenue stream and dent the pipeline's credibility. This follows the CFO's planned retirement and a $10.7B IRS dispute, adding to a growing list of headwinds. The hearing outcome will be the next major catalyst — no date yet set.

At the time of this announcement, AMGN was trading at $373.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $200.5B. The 52-week trading range was $269.77 to $391.29. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $458.60 info
Change: -$18.80 (-4%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $458.60 info
Change: -$6.32 (-1%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $458.60 info
Change: -$4.40 (-0.95%) info
Market Cap: $248.842B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $458.60 info
Change: -$1.97 (-0.43%) info
Market Cap: $248.842B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $458.60 info
Change: +$9.81 (+2%) info
Market Cap: $248.842B info